Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × EBC-46 × Clear all

NCT05608876 2025-08-07

A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer

Phase 2 Active not recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Salivary Gland Neoplasms